Literature DB >> 12636257

Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family.

Naoko Morinaga1, Yuriko Kaihou, Masatoshi Noda.   

Abstract

Staphylococcus aureus produces bi-component leukotoxins composed of non-associated soluble proteins, S and F. Neither S nor F component alone is cytotoxic, but components together are active. These include Panton-Valentine leukocidin (PVL), gamma-hemolysin, LukE-LukD and others. Purification of leukotoxin from Staphylococcus aureus V8 strain (ATCC 27733) which does not have PVL genes, identified an F component with 100% identical to that of PVL in the first twenty-five N-terminal amino acids. Molecular cloning of this toxin obtained 2,595 nucleotides sequences containing two novel open reading frames for S and F. Deduced amino acid sequences of the S and F were respectively 91 and 94% identical to those of LukE and LukD. These were named variant of LukE-LukD (LukEv-LukDv). The activity of the recombinant LukEv-LukDv to rabbit leukocytes was similar to that of recombinant PVL. LukEv-LukDv was hemolytic to rabbit red blood cells although the activity was only 8% of gamma-hemolysin, but PVL was not. These activities were quite different from the LukE-LukD which was reported no hemolytic and poorly cytotoxic to leukocytes compared to PVL. The lukEv-IukDv was found in 87% of clinical isolates of Staphylococcus aureus but lukE-lukD was not detected. These data demonstrate the existence of variant LukE-LukD in V8 strain (ATCC 27733).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636257     DOI: 10.1111/j.1348-0421.2003.tb02789.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  34 in total

1.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

2.  Crystallization and preliminary crystallographic studies of both components of the staphylococcal LukE-LukD leukotoxin.

Authors:  Romain Galy; Fabien Bergeret; Daniel Keller; Lionel Mourey; Gilles Prévost; Laurent Maveyraud
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23

Review 3.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

4.  Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia.

Authors:  Richa Hanamsagar; Victor Torres; Tammy Kielian
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

Review 5.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

Review 6.  Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.

Authors:  András N Spaan; Jos A G van Strijp; Victor J Torres
Journal:  Nat Rev Microbiol       Date:  2017-04-19       Impact factor: 60.633

Review 7.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

8.  Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis.

Authors:  Ashley L Dumont; Tyler K Nygaard; Robert L Watkins; Amanda Smith; Lina Kozhaya; Barry N Kreiswirth; Bo Shopsin; Derya Unutmaz; Jovanka M Voyich; Victor J Torres
Journal:  Mol Microbiol       Date:  2010-12-13       Impact factor: 3.501

9.  Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionization-mass spectrometry and correlation with phenotype.

Authors:  Donna M Wolk; Lawrence B Blyn; Thomas A Hall; Rangarajan Sampath; Raymond Ranken; Cristina Ivy; Rachael Melton; Heather Matthews; Neill White; Feng Li; Vanessa Harpin; David J Ecker; Brandi Limbago; Linda K McDougal; Vicki H Wysocki; Mian Cai; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

Review 10.  Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids.

Authors:  Ashley L DuMont; Victor J Torres
Journal:  Trends Microbiol       Date:  2013-11-11       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.